SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTriple Point Ve Regulatory News (TPV)

Share Price Information for Triple Point Ve (TPV)

Share Price is delayed by 15 minutes
Get Live Data
86.00    0.00 (0.00%)
Bid:
84.50
Ask:
87.50
Spread: 3.00 (3.55%)
Market Cap: £114.69m
TPV Live PriceLast checked at - London Stock Exchange

Intraday Triple Point Ve Share Chart

Interim Management Statement

16 Jan 2009 15:40

RNS Number : 8027L
TP70 VCT Plc
16 January 2009
 



TP70 VCT plc

 16 January 2009 

Interim Management Statement for the Quarter Ended 31 December 2008

TP70 VCT plc presents its interim management statement for the quarter ended 31 December 2008, which is the company's second interim management statement for the 11 months ended 28 February 2009, as required by the UK Listing Authority's Disclosure and Transparency Rule 4.3

Net assets at 31 December 2008 comprised:-

Unaudited

31 December 2008

Unaudited

30 September 2008

Audited

31 March 2008

£'000

%

£'000

%

£'000

%

Financial assets at fair value

25,155

97.5

27,017

97.6

29,255

98.4

Net current assets

635

2.5

654

2.4

470

1.6

25,790

100.0

27,671

100.0

30,534

100.0

Investment Activity

The financial assets at fair value figure represents the company's exposure both directly and indirectly to GAM Diversity. During calendar year 2008 GAM Diversity disappointingly returned -14.6% in sterling terms. This return outperformed the major hedge fund performance indices and also compares favourably with the decline of 29.9% in the FTSE All-Share index. 

Material Events and Transactions

During the quarter no shares were issued and no shares were purchased by the company for cancellation. 

In December the board resolved to change the company's balance sheet date to 28 February in order that the company has the maximum period available to make VCT qualifying investments. As a result, the next audited accounts will be those for the 11 months ended 28 February 2009.

As outlined above, in 2008 GAM Diversity succeeded in isolating investors from the worst excesses of asset value collapses and was also creditably resilient amidst well-publicised hedge fund redemptions. However, to ensure that GAM Diversity's redemption conditions remained in line with market practice, GAM Diversity gave notice in December to extend the period required to realise investments from monthly on 45 days' notice to quarterly on 95 days' notice.

£21,527,000 out of financial assets at fair value of £25,155,000 are exposed to GAM Diversity via a derivative transaction with Barclays Capital. Following GAM Diversity's change in redemption terms, Barclays Capital has very recently invoked early termination clauses to terminate the derivative transaction. As matters standTP70 will therefore cease to have exposure to GAM Diversity on 31 March 2008. The precise financial implications  of  termination have yet to be crystallised or agreed. However, the board and Triple Point Investment Management LLP are addressing the termination as a matter of priority, with a view to re-establishing  means for exposure to GAM Diversity, as well as investigating the possibility of offering those shareholders who are so disposed the option of extending exposure to GAM Diversity over the next 3 years via GAM Diversity 2.5XL. Further communication will follow in due course. 

Further Information

For further information, please contact David Dick or Chris Tottle at Triple Point Investment Management LLP on 0207 201 8989.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSBFMATMMJBBLL
Date   Source Headline
17th Mar 202512:20 pmRNSIssue of Equity and Total Voting Rights
11th Mar 20253:13 pmRNSTransaction in Own Shares
11th Mar 202510:42 amRNSIssue of Equity and Total Voting Rights
3rd Mar 202510:46 amRNSTotal Voting Rights
26th Feb 202512:14 pmRNSIssue of Equity and Total Voting Rights
13th Feb 20259:10 amRNSOffer for Subscription - over-allotment facility
10th Feb 20252:10 pmRNSIssue of Equity and Total Voting Rights
30th Jan 20252:11 pmRNSVenture Share Class Net Asset Value
6th Jan 20257:00 amRNSDividend Declaration
2nd Jan 20257:00 amRNSTotal Voting Rights
23rd Dec 20247:00 amRNSOffer for Subscription - over-allotment facility
19th Dec 20243:07 pmRNSIssue of Equity and Total Voting Rights
2nd Dec 20247:05 amRNSIssue of Equity and Total Voting Rights
2nd Dec 20247:00 amRNSTotal Voting Rights
18th Nov 20244:00 pmRNSTransaction in Own Shares
12th Nov 20242:13 pmRNSIssue of Equity and Total Voting Rights
29th Oct 20244:05 pmRNSIssue of Equity and Total Voting Rights
23rd Oct 20247:00 amRNSResults for the six months ended 31 August 2024
2nd Oct 202410:59 amRNSDirector Declaration
30th Sep 20247:00 amRNSDividend Declaration
26th Sep 20243:30 pmRNSResult of General Meeting
4th Sep 202412:32 pmRNSPublication of a Prospectus and Circular
2nd Sep 202412:00 pmRNSTotal Voting Rights
9th Aug 20241:30 pmRNSTransaction in Own Shares
1st Aug 202410:30 amRNSTotal Voting Rights
1st Aug 20247:00 amRNSIntention to Launch an Offer for Subscription
31st Jul 20243:57 pmRNSIssue of Equity and Total Voting Rights
24th Jul 20247:00 amRNSVenture Share Class Net Asset Value
23rd Jul 20242:09 pmRNSResult of Annual General Meeting
4th Jul 20244:58 pmRNSTransaction in Own Shares
1st Jul 20244:42 pmRNSChange of Registered Office
1st Jul 20244:36 pmRNSTotal Voting Rights
27th Jun 20243:30 pmRNSIssue of Equity and Total Voting Rights
12th Jun 20245:29 pmRNSAnnual Financial Report and Notice of AGM
3rd Jun 20247:00 amRNSFinal Results for the year ended 29 February 2024
1st May 20247:00 amRNSTotal Voting Rights
5th Apr 20242:48 pmRNSIssue of Equity and Total Voting Rights
4th Apr 20243:01 pmRNSIssue of Equity and Total Voting Rights
2nd Apr 20242:00 pmRNSIssue of Equity and Total Voting Rights
2nd Apr 20247:00 amRNSTotal Voting Rights
26th Mar 20247:00 amRNSOffer for Subscription - over-allotment facility
18th Mar 20247:00 amRNSIssue of Equity and Total Voting Rights
5th Mar 20242:50 pmRNSIssue of Equity and Total Voting Rights
13th Feb 202412:30 pmRNSIssue of Equity and Total Voting Rights
9th Feb 20247:00 amRNSOffer for Subscription - over-allotment facility
8th Feb 20243:30 pmRNSVenture Share Class Net Asset Value
8th Feb 20242:00 pmRNSDirectorate Change
4th Jan 20249:41 amRNSTotal Voting Rights
3rd Jan 20247:00 amRNSDividend Declaration
21st Dec 20231:33 pmRNSIssue of Equity and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.